癌症研究
锡尔图因
化学
雌激素受体
SIRT3
细胞凋亡
MCF-7型
SIRT6型
癌细胞
生物
下调和上调
雌激素
细胞培养
细胞生长
转录因子
细胞生物学
雌激素受体α
作者
Marija Pinterić,Iva I. Podgorski,Marijana Popović Hadžija,Vedrana Filić,Mladen Paradžik,Bastien Lucien Jean Proust,Ana Dekanić,Ivan Ciganek,Denis Pleše,Dora Marčinko,Tihomir Balog,Sandra Sobočanec
出处
期刊:Antioxidants
[Multidisciplinary Digital Publishing Institute]
日期:2020-04-01
卷期号:9 (4): 294-
被引量:3
标识
DOI:10.3390/antiox9040294
摘要
Estrogen (E2) is a major risk factor for the initiation and progression of malignancy in estrogen receptor (ER) positive breast cancers, whereas sirtuin 3 (Sirt3), a major mitochondrial NAD+-dependent deacetylase, has the inhibitory effect on the tumorigenic properties of ER positive MCF-7 breast cancer cells. Since it is unclear if this effect is mediated through the estrogen receptor alpha (ERα) signaling pathway, in this study, we aimed to determine if the tumor-suppressive function of Sirt3 in MCF-7 cells interferes with their response to E2. Although we found that Sirt3 improves the antioxidative response and mitochondrial fitness of the MCF-7 cells, it also increases DNA damage along with p53, AIF, and ERα expression. Moreover, Sirt3 desensitizes cells to the proliferative effect of E2, affects p53 by disruption of the ERα–p53 interaction, and decreases proliferation, colony formation, and migration of the cells. Our observations indicate that these tumor-suppressive effects of Sirt3 could be reversed by E2 treatment only to a limited extent which is not sufficient to recover the tumorigenic properties of the MCF-7 cells. This study provides new and interesting insights with respect to the functional role of Sirt3 in the E2-dependent breast cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI